2024 State of Gaming Report
RESTON, VA, June 7, 2017 – Comscore today announced that leaders from the company will be presenting at the Advertising Research Foundation’s (ARF) Audience Measurement 2017 conference. The event – “Modern Measurement: Media, Models & Methods” -- runs from Sunday, June 11 through Tuesday, June 13 and will be held at the Hyatt Regency Hotel in Jersey City, New Jersey.
Representatives from Comscore are participating in the following sessions:
Audience Measurement Best Practices in the Cross-Platform Age
Embrace Disruption: Home Sweet Digital Home
Measuring Brand Value across Platforms to Prove Sponsorship Effectiveness
Omnichannel Optimizing for the Data Generation
For more information about the event, please visit https://thearf.org/audience-measurement-2017/.
About ComscoreComscore is a leading cross-platform measurement company that measures audiences, brands and consumer behavior everywhere. Comscore completed its merger with Rentrak Corporation in January 2016, to create the new model for a dynamic, cross-platform world. Built on precision and innovation, Comscore’s data footprint combines proprietary digital, TV and movie intelligence with vast demographic details to quantify consumers’ multiscreen behavior at massive scale. This approach helps media companies monetize their complete audiences and allows marketers to reach these audiences more effectively. With more than 3,200 clients and a global footprint in more than 75 countries, Comscore is delivering the future of measurement. Shares of Comscore stock are currently traded on the OTC Market (OTC:SCOR). For more information on Comscore, please visit comscore.com.
Contact:Kate DreyerComscore, Inc. +1 (571) 306-6447press@comscore.com
Comscore Audience Activation™ offers programmatic targeting segments powered by massive cross-platform media consumption datasets such as demographics, TV viewership,...
Request a demo
Comscore MMX® Multi-Platform provides an deduplicated view of total audience behavior across desktops, smartphones and tablets.